Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis
Related Posts
McSwiggin H, Wang R, Magalhães RDM, Zhu F, Doherty TA, Yan W, Jendzjowsky N. Comprehensive sequencing of the lung neuroimmune landscape in response to asthmatic[...]
Han D, Tzolos E, Park R, Gransar H, Hyun M, Friedman JD, Hayes SW, Thomson LEJ, Kwan AC, Budoff M, Shah PK, Kwieciński J, Wetzel[...]
Gebremariam T, Gu Y, Patterson H, Youssef E, Alkhazraji S, Elsayed T, Wiederhold NP, Ibrahim AS. Efficacy assessments of SF001, a next-generation polyene antifungal, in[...]